BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3940838)

  • 41. Phenprocoumon therapy during pregnancy: case report and comparison of the teratogenic risk of different coumarin derivatives.
    Gärtner BC; Seifert CB; Michalk DV; Roth B
    Z Geburtshilfe Perinatol; 1993; 197(6):262-5. PubMed ID: 8147045
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Hypertrophic Darier's disease of unusual intensity. Enzymatic and ultrastructural study and therapeutic response].
    Grasa MP; Bosch R; Abascal M; Domínquez M; Carapeto FJ
    Actas Dermosifiliogr; 1981; 72(11-12):557-64. PubMed ID: 7344430
    [No Abstract]   [Full Text] [Related]  

  • 43. [Cyclosporine and Darier's disease].
    Larbre B; Nicolas JF; Frappaz A; Thivolet J
    Ann Dermatol Venereol; 1993; 120(4):310-1. PubMed ID: 8239382
    [No Abstract]   [Full Text] [Related]  

  • 44. Possible long-term teratogenic effect of isotretinoin in pregnancy.
    Malvasi A; Tinelli A; Buia A; De Luca GF
    Eur Rev Med Pharmacol Sci; 2009; 13(5):393-6. PubMed ID: 19961047
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Congenital ichthyosiforme erythroderma, pregnancy under aromatic retinoid treatment].
    Jäger K; Schiller F; Stech P
    Hautarzt; 1985 Mar; 36(3):150-3. PubMed ID: 3997513
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical and ultrastructural effects of acitretin in Darier's disease.
    Lauharanta J; Kanerva L; Turjanmaa K; Geiger JM
    Acta Derm Venereol; 1988; 68(6):492-8. PubMed ID: 2467487
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Pregnancy, contraception and epilepsy].
    Leppert D; Wieser HG
    Nervenarzt; 1993 Aug; 64(8):494-503. PubMed ID: 8413747
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oral treatment of keratinizing disorders of skin and mucous membranes with etretinate. Comparative study of 113 patients.
    Mahrle G; Meyer-Hamme S; Ippen H
    Arch Dermatol; 1982 Feb; 118(2):97-100. PubMed ID: 7059226
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Darier's disease and renal polycystosis. Familial study and effects of aromatic retinoid].
    Claudy A; Toulon J; Dutoit M; Sabatier JC; Berthoux FC
    Ann Dermatol Venereol; 1981; 108(8-9):675-7. PubMed ID: 7316395
    [No Abstract]   [Full Text] [Related]  

  • 50. Two siblings with fetal hydantoin syndrome.
    Ozkinay F; Yenigün A; Kantar M; Ozkinay C; Avanoğlu A; Ulman I
    Turk J Pediatr; 1998; 40(2):273-8. PubMed ID: 9677735
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Electrosurgical treatment of etretinate-resistant Darier's disease.
    Toombs EL; Peck GL
    J Dermatol Surg Oncol; 1989 Dec; 15(12):1277-80. PubMed ID: 2592667
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Etretinate and pregnancy.
    Lammer E
    Lancet; 1989 Jan; 1(8629):109. PubMed ID: 2562875
    [No Abstract]   [Full Text] [Related]  

  • 53. [Retinoids and congenital malformations].
    van der Schroeff JG
    Ned Tijdschr Geneeskd; 1986 Apr; 130(14):622-3. PubMed ID: 3458029
    [No Abstract]   [Full Text] [Related]  

  • 54. Multiple congenital anomalies in a fetus exposed to 5-fluorouracil during the first trimester.
    Stephens JD; Golbus MS; Miller TR; Wilber RR; Epstein CJ
    Am J Obstet Gynecol; 1980 Jul; 137(6):747-9. PubMed ID: 7395946
    [No Abstract]   [Full Text] [Related]  

  • 55. 6-Mercaptopurine teratogenicity.
    Tegay DH; Tepper R; Willner JP
    Postgrad Med J; 2002 Sep; 78(923):572; author reply 572. PubMed ID: 12357029
    [No Abstract]   [Full Text] [Related]  

  • 56. Teratogenic dose-response relationships of etretinate in the golden hamster.
    Williams KJ; Ferm VH; Willhite CC
    Fundam Appl Toxicol; 1984 Dec; 4(6):977-82. PubMed ID: 6519378
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oral retinoid (Tigason R etretinate) therapy in congenital disorders of keratinisation.
    Rajan VS; Thirumoorthy T
    Ann Acad Med Singap; 1983 Jan; 12(1):45-51. PubMed ID: 6222685
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Bone changes in long-term therapy with etretinate (Tigason)].
    Haustein UF; Heilmann S
    Z Hautkr; 1987 Mar; 62(5):395-6, 399-400. PubMed ID: 3590912
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pontoneocerebellar hypoplasia--a probable consequence of prenatal destruction of the pontine nuclei and a possible role of phenytoin intoxication.
    Gadisseux JF; Rodriguez J; Lyon G
    Clin Neuropathol; 1984; 3(4):160-7. PubMed ID: 6478678
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antiepileptic drug therapy and congenital defects.
    Mastroiacovo P; Botto L; Serafini M; Zampino G
    Ann Ist Super Sanita; 1993; 29(1):77-87. PubMed ID: 8129275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.